CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Tofacitinib
Brand Name: Xeljanz
Manufacturer: Pfizer Canada Inc.
Indications: Arthritis, Rheumatoid
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: April 17, 2015
Recommendation Type: List with criteria/condition
